16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Immune biomarkers link air pollution exposure to blood pressure in adolescents

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract
          Background

          Childhood exposure to air pollution contributes to cardiovascular disease in adulthood. Immune and oxidative stress disturbances might mediate the effects of air pollution on the cardiovascular system, but the underlying mechanisms are poorly understood in adolescents. Therefore, we aimed to identify immune biomarkers linking air pollution exposure and blood pressure levels in adolescents.

          Methods

          We randomly recruited 100 adolescents (mean age, 16 years) from Fresno, California. Using central-site data, spatial-temporal modeling, and distance weighting exposures to the participant’s home, we estimated average pollutant levels [particulate matter (PM), polyaromatic hydrocarbons (PAH), ozone (O 3), carbon monoxide (CO) and nitrogen oxides (NO x)]. We collected blood samples and vital signs on health visits. Using proteomic platforms, we quantitated markers of inflammation, oxidative stress, coagulation, and endothelial function. Immune cellular characterization was performed via mass cytometry (CyTOF). We investigated associations between pollutant levels, cytokines, immune cell types, and blood pressure (BP) using partial least squares (PLS) and linear regression, while adjusting for important confounders.

          Results

          Using PLS, biomarkers explaining most of the variance in air pollution exposure included markers of oxidative stress (GDF-15 and myeloperoxidase), acute inflammation (C-reactive protein), hemostasis (ADAMTS, D-dimer) and immune cell types such as monocytes. Most of these biomarkers were independently associated with the air pollution levels in fully adjusted regression models. In CyTOF analyses, monocytes were enriched in participants with the highest versus the lowest PM 2.5 exposure. In both PLS and linear regression, diastolic BP was independently associated with PM 2.5, NO, NO 2, CO and PAH 456 pollution levels ( P ≤ 0.009). Moreover, monocyte levels were independently related to both air pollution and diastolic BP levels ( P ≤ 0.010). In in vitro cell assays, plasma of participants with high PM 2.5 exposure induced endothelial dysfunction as evaluated by eNOS and ICAM-1 expression and tube formation.

          Conclusions

          For the first time in adolescents, we found that ambient air pollution levels were associated with oxidative stress, acute inflammation, altered hemostasis, endothelial dysfunction, monocyte enrichment and diastolic blood pressure. Our findings provide new insights on pollution-related immunological and cardiovascular disturbances and advocate preventative measures of air pollution exposure.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: not found

          Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association.

          In 2004, the first American Heart Association scientific statement on "Air Pollution and Cardiovascular Disease" concluded that exposure to particulate matter (PM) air pollution contributes to cardiovascular morbidity and mortality. In the interim, numerous studies have expanded our understanding of this association and further elucidated the physiological and molecular mechanisms involved. The main objective of this updated American Heart Association scientific statement is to provide a comprehensive review of the new evidence linking PM exposure with cardiovascular disease, with a specific focus on highlighting the clinical implications for researchers and healthcare providers. The writing group also sought to provide expert consensus opinions on many aspects of the current state of science and updated suggestions for areas of future research. On the basis of the findings of this review, several new conclusions were reached, including the following: Exposure to PM <2.5 microm in diameter (PM(2.5)) over a few hours to weeks can trigger cardiovascular disease-related mortality and nonfatal events; longer-term exposure (eg, a few years) increases the risk for cardiovascular mortality to an even greater extent than exposures over a few days and reduces life expectancy within more highly exposed segments of the population by several months to a few years; reductions in PM levels are associated with decreases in cardiovascular mortality within a time frame as short as a few years; and many credible pathological mechanisms have been elucidated that lend biological plausibility to these findings. It is the opinion of the writing group that the overall evidence is consistent with a causal relationship between PM(2.5) exposure and cardiovascular morbidity and mortality. This body of evidence has grown and been strengthened substantially since the first American Heart Association scientific statement was published. Finally, PM(2.5) exposure is deemed a modifiable factor that contributes to cardiovascular morbidity and mortality.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Immunological and inflammatory functions of the interleukin-1 family.

            More than any other cytokine family, the interleukin (IL)-1 family is closely linked to the innate immune response. This linkage became evident upon the discovery that the cytoplasmic domain of the IL-1 receptor type I is highly homologous to the cytoplasmic domains of all Toll-like receptors (TLRs). Thus, fundamental inflammatory responses such as the induction of cyclooxygenase type 2, increased expression of adhesion molecules, or synthesis of nitric oxide are indistinguishable responses of both IL-1 and TLR ligands. Both families nonspecifically affect antigen recognition and lymphocyte function. IL-1beta is the most studied member of the IL-1 family because of its role in mediating autoinflammatory diseases. Although the TLR and IL-1 families evolved to assist in host defense against infection, unlike the TLR family, the IL-1 family also includes members that suppress inflammation, both specifically within the IL-1 family but also nonspecifically for TLR ligands and the innate immune response.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease

                Bookmark

                Author and article information

                Contributors
                prunicki@stanford.edu
                nicholas.cauwenberghs@kuleuven.be
                jarthur5@stanford.edu
                hesamov@stanford.edu
                kimjb@stanford.edu
                tanyagr@rambler.ru
                joewu@stanford.edu
                maecker@stanford.edu
                fhaddad@stanford.edu
                knadeau@stanford.edu
                Journal
                Environ Health
                Environ Health
                Environmental Health
                BioMed Central (London )
                1476-069X
                16 October 2020
                16 October 2020
                2020
                : 19
                : 108
                Affiliations
                [1 ]GRID grid.168010.e, ISNI 0000000419368956, Sean N Parker Center for Allergy and Asthma Research, , Stanford University, ; Stanford, USA
                [2 ]GRID grid.5596.f, ISNI 0000 0001 0668 7884, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, , University of Leuven, ; Leuven, Belgium
                [3 ]Research and Innovation Unit, INSERM U999, DHU TORINO, Paris Sud University, Marie Lannelongue Hospital, Le Plessis Robinson, France
                [4 ]GRID grid.168010.e, ISNI 0000000419368956, Institute for Immunity, Transplantation, and Infection, , Stanford University, ; Stanford, USA
                [5 ]GRID grid.168010.e, ISNI 0000000419368956, Division of Cardiovascular Medicine, Department of Medicine, , Stanford University, ; Stanford, USA
                [6 ]GRID grid.168010.e, ISNI 0000000419368956, Stanford Cardiovascular Institute, , Stanford University School of Medicine, ; Stanford, USA
                Author information
                http://orcid.org/0000-0002-2146-2955
                Article
                662
                10.1186/s12940-020-00662-2
                7566149
                33066786
                2b99fa8d-79b2-4f49-8c8d-cba1b4267018
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 9 April 2020
                : 1 October 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: NIEHS R01ES02092
                Award ID: NIEHS R01ES020926
                Award ID: 3R01ES020926
                Funded by: NIH
                Award ID: NHLBI R01HL081521
                Funded by: FundRef http://dx.doi.org/10.13039/100006521, School of Medicine, Stanford University;
                Award ID: Sean Parker Center for Allergy and Asthma Research
                Categories
                Research
                Custom metadata
                © The Author(s) 2020

                Public health
                adolescent,blood pressure,immune,inflammation,air pollution,cardiovascular disease
                Public health
                adolescent, blood pressure, immune, inflammation, air pollution, cardiovascular disease

                Comments

                Comment on this article